Mengqi Lu

机构：Wenzhou Medical University, Shanghai Cell Therapy Research Institute

发表论文 12 篇 · 总被引 318 次 · h-index 6

代表论文

PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation (2018 · Cancer Letters · 被引 122)
CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis (2020 · Biochemical and Biophysical Research Communications · 被引 46)
ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway (2020 · PeerJ · 被引 44)
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer (2018 · Biochemical and Biophysical Research Communications · 被引 42)
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers (2016 · Oncotarget · 被引 40)
Hormonally and chemically defined expansion conditions for organoids of biliary tree Stem Cells (2024 · Bioactive Materials · 被引 9)